Header Logo

Connection

Groesbeck Parham to Middle Aged

Back to Details
This is a "connection" page, showing publications Groesbeck Parham has written about Middle Aged.
Groesbeck Parham
Connection Strength
2.220
Middle Aged
  1. A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial. Nat Med. 2024 Sep; 30(9):2596-2604.
    View in: PubMed
    Score: 0.159
  2. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia. Cancer Med. 2024 Jun; 13(11):e7355.
    View in: PubMed
    Score: 0.158
  3. Three-year survival of breast cancer patients attending a one-stop breast care clinic nested within a primary care health facility in sub-Saharan Africa-Zambia. Int J Cancer. 2024 Jul 15; 155(2):261-269.
    View in: PubMed
    Score: 0.156
  4. The Ability to Look: Management of Breast Disease in the Democratic Republic of the Congo Using Smart Ultrasound Technology. J Am Coll Surg. 2021 04; 232(4):636-640.
    View in: PubMed
    Score: 0.124
  5. Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia. Int J Gynaecol Obstet. 2019 Mar; 144(3):297-301.
    View in: PubMed
    Score: 0.109
  6. Demonstration of an algorithm to overcome health system-related barriers to timely diagnosis of breast diseases in rural Zambia. PLoS One. 2018; 13(5):e0196985.
    View in: PubMed
    Score: 0.104
  7. Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. J Glob Oncol. 2018 09; 4:1-8.
    View in: PubMed
    Score: 0.099
  8. Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis. 2016 Jul; 20(3):218-23.
    View in: PubMed
    Score: 0.091
  9. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169.
    View in: PubMed
    Score: 0.084
  10. Strategies for achieving healthy energy balance among African Americans in the Mississippi Delta. Prev Chronic Dis. 2007 Oct; 4(4):A97.
    View in: PubMed
    Score: 0.050
  11. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006 Dec; 103(3):1017-22.
    View in: PubMed
    Score: 0.046
  12. Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort. J Natl Cancer Inst. 2025 Nov 01; 117(11):2298-2307.
    View in: PubMed
    Score: 0.044
  13. Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 2025 Oct; 13(10):e1681-e1690.
    View in: PubMed
    Score: 0.043
  14. Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol. 2005 Nov; 99(2):432-6.
    View in: PubMed
    Score: 0.043
  15. Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia. Bull World Health Organ. 2025 Sep 01; 103(9):530-540.
    View in: PubMed
    Score: 0.043
  16. Vaginal microbiome composition in women with HIV undergoing treatment of cervical transformation zone in a screen and treat program in Zambia. AIDS. 2025 Jul 15; 39(9):1303-1306.
    View in: PubMed
    Score: 0.042
  17. Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 2024 Jul; 12(7):e1111-e1119.
    View in: PubMed
    Score: 0.039
  18. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1345-55.
    View in: PubMed
    Score: 0.036
  19. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med. 2002 May 30; 346(22):1752-3.
    View in: PubMed
    Score: 0.034
  20. Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res. 2002 May; 8(5):1271-9.
    View in: PubMed
    Score: 0.034
  21. Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study. Breast Cancer Res. 2021 11 24; 23(1):109.
    View in: PubMed
    Score: 0.033
  22. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer. BJOG. 2001 Aug; 108(8):804-8.
    View in: PubMed
    Score: 0.032
  23. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Gynecol Obstet Invest. 2001; 51(4):254-61.
    View in: PubMed
    Score: 0.031
  24. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):997-1006.
    View in: PubMed
    Score: 0.031
  25. Few Losses to Follow-up in a Sub-Saharan African Cancer Cohort via Active Mobile Health Follow-up. Am J Epidemiol. 2020 10 01; 189(10):1185-1196.
    View in: PubMed
    Score: 0.031
  26. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Obstet Gynecol. 2000 Sep; 96(3):422-30.
    View in: PubMed
    Score: 0.030
  27. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Am J Obstet Gynecol. 2000 Sep; 183(3):601-9.
    View in: PubMed
    Score: 0.030
  28. Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 2020 09; 8(9):e1203-e1212.
    View in: PubMed
    Score: 0.030
  29. Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: Findings from the multicountry ABC-DO cohort study. Int J Cancer. 2021 01 15; 148(2):340-351.
    View in: PubMed
    Score: 0.030
  30. Comparison of immediate and deferred colposcopy in a cervical screening program. Obstet Gynecol. 2000 Mar; 95(3):340-4.
    View in: PubMed
    Score: 0.029
  31. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020 01; 21(1):175-184.
    View in: PubMed
    Score: 0.029
  32. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Obstet Gynecol. 1999 Jul; 94(1):78-82.
    View in: PubMed
    Score: 0.028
  33. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol. 1999; 20(3):177-81.
    View in: PubMed
    Score: 0.027
  34. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.
    View in: PubMed
    Score: 0.027
  35. Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer - disparities in outcomes (ABC-DO) study. Int J Cancer. 2018 04 15; 142(8):1568-1579.
    View in: PubMed
    Score: 0.025
  36. Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: a community-based clinical trial. Obstet Gynecol. 1997 Sep; 90(3):421-7.
    View in: PubMed
    Score: 0.025
  37. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer. 1997 Aug 15; 80(4):816-26.
    View in: PubMed
    Score: 0.025
  38. The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia. J Low Genit Tract Dis. 2015 Oct; 19(4):301-6.
    View in: PubMed
    Score: 0.022
  39. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015 Jul 24; 15:541.
    View in: PubMed
    Score: 0.021
  40. Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia. J Low Genit Tract Dis. 2015 Apr; 19(2):119-23.
    View in: PubMed
    Score: 0.021
  41. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):212-5.
    View in: PubMed
    Score: 0.020
  42. Innovative approaches to promoting cervical health and raising cervical cancer awareness by use of existing cultural structures in resource-limited countries: experiences with traditional marriage counseling in Zambia. Glob Health Promot. 2013 Dec; 20(4 Suppl):57-64.
    View in: PubMed
    Score: 0.019
  43. Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia. J Psychosom Obstet Gynaecol. 2012 Jun; 33(2):91-8.
    View in: PubMed
    Score: 0.017
  44. A community-driven action plan to eliminate breast and cervical cancer disparity: successes and limitations. J Cancer Educ. 2006; 21(1 Suppl):S91-100.
    View in: PubMed
    Score: 0.011
  45. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005 Nov 20; 23(33):8289-95.
    View in: PubMed
    Score: 0.011
  46. Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest. 2003; 56(1):28-34.
    View in: PubMed
    Score: 0.009
  47. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol. 2003 Feb; 188(2):395-400.
    View in: PubMed
    Score: 0.009
  48. Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer. Br J Cancer. 2002 Jan 07; 86(1):151-7.
    View in: PubMed
    Score: 0.008
  49. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol. 2001 Jun; 81(3):424-32.
    View in: PubMed
    Score: 0.008
  50. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 1998 12 15; 83(12):2629-37.
    View in: PubMed
    Score: 0.007
  51. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol. 1995 May; 85(5 Pt 1):709-15.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.